Effect of Ropivacaine injection in controlling bleeding during tonsillectomy surgery

Efficacy Of Ropivacaine As A Local Infiltrative Drug On Tonsillectomy Haemorrhage- A Randomized Controlled Trial. - NIL

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081861

Enrollment

Registered

2025-03-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J351- Hypertrophy of tonsils

Interventions

Intervention1: Ropivacaine infiltration- given: Local infiltration with 0.5% Ropivacaine will be given in peritonsillar space during tonsillectomy. Control Intervention1: Ropivacaine infiltration- not

Eligibility

Inclusion criteria

Inclusion criteria: Patients who offered informed written consent/ parental informed written consent to undergo procedure. Patients between the age group of 5 to 30 years Patients with chronic tonsillitis with or without adenoid hypertrophy

Exclusion criteria

Exclusion criteria: Patients with acute pharyngeal infection Patients with anemia, systemic hypertension Patients with associated cardiac, hepatic, or haematological diseases. Patients with history of hypersensitivity to amide group of anaesthetic drugs

Design outcomes

Primary

Measure	Time frame
1. Intra-operative bleed 2. Post tonsillectomy haemorrhageTimepoint: 1. Baseline 2. 24 hours, 48 hours	—

Secondary

Measure	Time frame
Post operative analgesiaTimepoint: 6 hours, 24 hours, 48 hours	—

Countries

India

Contacts

Public ContactSulekha Naresh

Associate professor

sivaranjani57@gmail.com8056048496

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026